Hikma Pharmaceuticals USA Inc.
H-1B Sponsorship & Salary Data — Government-Verified
$111,223Avg. Salary
18Filings
16+Job Titles
November 2025Last Filing
According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), Hikma Pharmaceuticals USA Inc. pays a median H-1B salary of $110,365 — 9% below the national median of $121,514, ranking in the top 45% of 13,957 ranked H-1B sponsors. Based on 18 certified Labor Condition Applications.
Section 1
What does Hikma Pharmaceuticals USA Inc. pay?
Hikma Pharmaceuticals USA Inc.'s H-1B filings show an average salary of $111,223 based on 18 certified LCA applications. Salaries range from $79,498 to $152,693.
$111,223
Average
$110,365
Median
$79,498
Minimum
$152,693
Maximum
Recent H-1B Filings
| Job Title | Salary |
|---|---|
| Principal, Combination Products & Medical Device Expert | $96,782 |
| Scientist IV, QC Development & Lifecycle | $110,573 |
| Principal Scientist, Analytical Research | $101,566 |
| Senior Engineer, Computer Validation | $103,126 |
| Manager, IT SAP OTC | $148,450 |
| Principal Scientist, Analytical Research | $110,573 |
| Scientist, Analytical Research | $79,498 |
| Senior Process Engineer, Third Party Management | $110,365 |
| Principal Specialist, Regulatory Affairs | $111,925 |
| Associate Director, Regulatory Affairs | $134,285 |
| Senior Engineer, Equipment Validation | $101,816 |
| Manager, IT SAP BASIS & Security | $121,742 |
| Senior Manager, IT SAP ABAP | $152,693 |
| Manager, Regulatory Affairs | $120,453 |
| Sr. Scientist, Analytical Research | $84,677 |
| Manager, IT Business Partner - Revenue Operations | $144,000 |
| Scientist, Analytical Research | $79,498 |
| Sr. Scientist, Formulation Development | $90,000 |
Section 2
States with Hikma Pharmaceuticals USA Inc. H-1B Filings
Similar Companies
Section 3
All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.
Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.